Citations

Citations to this article as recorded by  

• Reply to correspondence on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”
  Eileen Laurel Yoon, Dae Won Jun
  Clinical and Molecular Hepatology.2024; 30(4): 1033.     CrossRef

Citations

Citations to this article as recorded by  

• Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases
  Yiyuan Xiao, Sihua Xu, Wenyan Hu, Jiapeng Huang, Deke Jiang, Rong Na, Zhaoqing Yin, Jingjing Zhang, Haitao Chen
  Annals of Hepatology.2025; 30(1): 101750.     CrossRef
• Alcohol Intake and Cardiometabolic Risk Factors Are Independently Associated With a Higher AST/Platelet Ratio Index in Obese Males
  Hideki Fujii, Yoshihiro Kamada, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Tsubasa Tsutsumi, Takemi Akahane, Chitomi Hasebe, Miwa Kawanaka, Takaomi Kessoku, Yuichiro Eguchi, Hayashi Syokita, Atsushi Nakajima, Tomoari Kam
  Liver International Communications.2025;[Epub]     CrossRef
• Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
  Toru Nakamura, Atsutaka Masuda, Dan Nakano, Keisuke Amano, Tomoya Sano, Masahito Nakano, Takumi Kawaguchi
  Cells.2025; 14(6): 428.     CrossRef
• Reducing complications of metabolic dysfunction–associated steatotic liver disease
  Naohiro Wada, Michihiro Iwaki, Takashi Kobayashi, Atsushi Nakajima, Masato Yoneda
  Expert Review of Gastroenterology & Hepatology.2025; 19(5): 577.     CrossRef
• Cardiometabolic dysfunction burden and mortality outcomes in metabolic dysfunction-associated steatotic liver disease
  Ying Wen, Yu Min, Yi Lei, Zhigong Wei, Sophia Eugenia Martínez-Vázquez
  PLOS One.2025; 20(7): e0327772.     CrossRef
• The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype–phenotype study
  Jaejun Lee, Jung Hoon Cha, Hee Sun Cho, Keungmo Yang, Hyun Yang, Heechul Nam, Mi Young Byun, Seok Keun Cho, Jinsung Park, Hyuk Wan Ko, Seong Wook Yang, Pil Soo Sung, Si Hyun Bae
  Journal of Gastroenterology.2025; 60(10): 1284.     CrossRef
• Effects of laser acupuncture (stress-free therapy) on blood liver function indicators
  Yoshihiro Kamada, Takunori Sato, Takaomi Kessoku, Yoshio Sumida, Masafumi Ono, Kenji Ryotokuji
  Laser Therapy.2025;[Epub]     CrossRef
• Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences
  Joo Hyun Oh, Dae Won Jun
  Clinical and Molecular Hepatology.2024; 30(2): 168.     CrossRef
• Correspondence on Letter regarding “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
  Hideki Fujii, Michihiro Iwaki, Yoshihiro Kamada
  Clinical and Molecular Hepatology.2024; 30(2): 281.     CrossRef
• Usefulness of health checkup‐based indices in identifying metabolic dysfunction‐associated steatotic liver disease
  Takao Miwa, Satoko Tajirika, Nanako Imamura, Miho Adachi, Ryo Horita, Tatsunori Hanai, Cheng Han Ng, Mohammad Shadab Siddiqui, Taku Fukao, Masahito Shimizu, Mayumi Yamamoto
  JGH Open.2024;[Epub]     CrossRef
• Association between nonalcholic fatty liver disease and pancreatic cancer: Epidemiology, mechanisms, and antidiabetic medication
  Takahiko Sakaue, Hiroya Terabe, Hidetoshi Takedatsu, Takumi Kawaguchi
  Hepatology Research.2024; 54(8): 729.     CrossRef
• Reply to correspondence on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”
  Eileen Laurel Yoon, Dae Won Jun
  Clinical and Molecular Hepatology.2024; 30(4): 1033.     CrossRef
• Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfun
  Yixuan Zhu, Xiaoyan Ma, Wenjing Ni, Yee Hui Yeo, Junping Shi, Jie Li
  Clinical and Molecular Hepatology.2024; 30(4): 974.     CrossRef
• Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
  Yeo-Wool Kang, Yang-Hyun Baek, Sang-Yi Moon
  Diagnostics.2024; 14(22): 2517.     CrossRef
• Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease
  Yun Kyu Lee, Dong Hyeon Lee, Sae Kyung Joo, Heejoon Jang, Young Ho So, Siwon Jang, Dong Ho Lee, Jeong Hwan Park, Mee Soo Chang, Won Kim
  Gut and Liver.2024; 18(6): 1048.     CrossRef

Citations

Citations to this article as recorded by  

• Prognostic value of circulating tumor DNA in different cancer types detected by ultra-low-pass whole-genome sequencing: a systematic review and patient-level survival data meta-analysis
  Miguel Sogbe, Daniel Aliseda, Paloma Sangro, Manuel de la Torre-Aláez, Bruno Sangro, Josepmaria Argemi
  Carcinogenesis.2025;[Epub]     CrossRef
• Liquid biopsy in hepatocellular carcinoma: Challenges, advances, and clinical implications
  Jaeho Park, Yi-Te Lee, Vatche G. Agopian, Jessica S Liu, Ekaterina K. Koltsova, Sungyong You, Yazhen Zhu, Hsian-Rong Tseng, Ju Dong Yang
  Clinical and Molecular Hepatology.2025; 31(Suppl): S255.     CrossRef
• Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study
  Elisa Pinto, Elisabetta Lazzarini, Filippo Pelizzaro, Martina Gambato, Laura Santarelli, Sara Potente, Paola Zanaga, Teresa Zappitelli, Romilda Cardin, Patrizia Burra, Fabio Farinati, Chiara Romualdi, Diego Boscarino, Valeria Tosello, Stefano Indraccolo,
  Cancers.2025; 17(7): 1115.     CrossRef
• Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage Hepatocellular Carcinoma in Liver and Blood
  Siyu Fu, Ruben G. Boers, Joachim B. Boers, Pam E. van der Meeren, Jean Helmijr, Vanja de Weerd, Michail Doukas, Maurice Jansen, Bettina E. Hansen, Roeland F. de Wilde, Dave Sprengers, Joost Gribnau, Saskia M. Wilting, José D. Debes, Andre Boonstra
  Journal of Experimental & Clinical Cancer Research.2025;[Epub]     CrossRef
• Redefining precision medicine in hepatocellular carcinoma through omics, translational, and AI-based innovations
  Rashi Jain, Sathish Kumar Mungamuri, Prabha Garg
  The Journal of Precision Medicine: Health and Disease.2025; 1: 100003.     CrossRef
• Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer
  Carolyn Hruban, Daniel C. Bruhm, Inna M. Chen, Shashikant Koul, Akshaya V. Annapragada, Nicholas A. Vulpescu, Sarah Short, Susann Theile, Kavya Boyapati, Bahar Alipanahi, Zachary L. Skidmore, Alessandro Leal, Stephen Cristiano, Vilmos Adleff, Julia S. Joh
  Science Advances.2025;[Epub]     CrossRef
• Shallow whole-genome sequencing of circulating tumour DNA predicts clinical outcomes to systemic therapy in advanced hepatocellular carcinoma
  Venkata Ramana Mallela, Sultan N. Alharbi, Mathew Vithayathil, Caroline Ward, Rishi Patel, Rohini Sharma
  European Journal of Cancer.2025; 227: 115633.     CrossRef
• Hepatic Metabolic Signature and Its Association with the Response to Immunotherapy in Hepatocellular Carcinoma
  Hyewon Park, Sowon Park, Kena Park, Sun Young Yim, Ju-Seog Lee, Sung Hwan Lee
  ImmunoTargets and Therapy.2025; Volume 14: 787.     CrossRef
• Dual tissue mRNA and serum protein signatures improve risk stratification in hepatocellular carcinoma
  Ding-Fan Guo, Lin-Wei Fan, Qi Wen, Jin-Ke Wang, Yun-Hui Liang, Qi Feng, Ting Wang, Kun-He Zhang
  npj Precision Oncology.2025;[Epub]     CrossRef
• Genomics and Epigenomics Approaches for the Quantification of Circulating Tumor DNA in Liquid Biopsy: Relevance of a Multimodal Strategy
  Elisa De Paolis, Alessia Perrucci, Gabriele Albertini Petroni, Alessandra Conca, Matteo Corsi, Andrea Urbani, Angelo Minucci
  International Journal of Molecular Sciences.2025; 26(22): 10982.     CrossRef
• Advances in the Diagnosis, Treatment, and Management of Liver Nodules: A Comprehensive Review
  Chang Gao, Dongyang Chen, Youpeng Chen
  Portal Hypertension & Cirrhosis.2025;[Epub]     CrossRef
• Research progress and frontier trends in liver cancer immunotherapy in the post-COVID-19 era (2020–2024): a visualization analysis based on bibliometric methods
  Shicai Liang, Xusheng Zhang, Xuebo Wang, Yannan Xie, Jialong Wang, Jiawei Wang, Bendong Chen
  Discover Oncology.2025;[Epub]     CrossRef
• Exploring the prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma
  Ji Eun Han, Hyo Jung Cho
  Clinical and Molecular Hepatology.2024; 30(2): 160.     CrossRef
• Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma
  Makoto Chuma, Haruki Uojima, Hidenori Toyoda, Atsushi Hiraoka, Yoshitake Arase, Masanori Atsukawa, Norio Itokawa, Tomomi Okubo, Toshifumi Tada, Kazushi Numata, Manabu Morimoto, Makoto Sugimori, Akito Nozaki, Shuichiro Iwasaki, Satoshi Yasuda, Yuichi Koshi
  Hepatology International.2024; 18(5): 1472.     CrossRef
• Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma
  Ji Yeon Lee, Pil Soo Sung
  Gut and Liver.2024; 18(4): 558.     CrossRef
• From haystack to high precision: advanced sequencing methods to unraveling circulating tumor DNA mutations
  Tamires Ferreira da Silva, Juscelino Carvalho de Azevedo, Eliel Barbosa Teixeira, Samir Mansour Moraes Casseb, Fabiano Cordeiro Moreira, Paulo Pimentel de Assumpção, Sidney Emanuel Batista dos Santos, Danielle Queiroz Calcagno
  Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
• Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”
  Su Bin Lim, Hyo Jung Cho
  Clinical and Molecular Hepatology.2024; 30(4): 1009.     CrossRef
• Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
  Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee
  Clinical and Molecular Hepatology.2024; 30(4): 807.     CrossRef
• Blood biomarkers of hepatocellular carcinoma: a critical review
  Junsheng Zhao, Zekai Hu, Xiaoping Zheng, Yajie Lin, Xiao Liu, Junjie Zhang, Jing Peng, Hainv Gao
  Frontiers in Cell and Developmental Biology.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis
  Mi Na Kim, Jihyun An, Eun Hwa Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Young-Joo Jin, Young Eun Chon, Seung Up Kim, Dae Won Jun, Ji Won Han, Miyoung Choi
  Clinical and Molecular Hepatology.2024; 30(Suppl): S106.     CrossRef
• Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
  Halil Haldun Emiroglu
  Clinical and Molecular Hepatology.2023; 29(3): 812.     CrossRef
• The Relationship between Mean Platelet Volume and Neutrophil–Lymphocyte Ratio and Liver Fibrosis in Patients with Chronic Hepatitis B
  Mehmet Onder Ekmen, Metin Uzman
  Medicina.2023; 59(7): 1287.     CrossRef

Citations

Citations to this article as recorded by  

• Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
  Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
  Clinical and Molecular Hepatology.2024; 30(3): 500.     CrossRef
• Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
  Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
  Clinical and Molecular Hepatology.2023; 29(3): 794.     CrossRef

Citations

Citations to this article as recorded by  

• Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
  Han Ah. Lee, Hyun Woong Lee, Yeon Seok Seo, Dong Hyun Sinn, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2025; 40(7): 1675.     CrossRef
• Unraveling Demographic Patterns in Hepatitis B Clinical and Laboratory Profiles: Insights From a Ghanaian Cohort: A Retrospective Study
  Napoleon Bellua Sam, Saeed Folorunsho Majeed, Adams Dramani
  Health Science Reports.2025;[Epub]     CrossRef
• Higher level of HBsAg associated with delayed development of HCC in immune-tolerant patients
  Tai-Chung Tseng, Tetsuya Hosaka, Mei-Hung Pan, Chun-Jen Liu, Fumitaka Suzuki, Chien-Jen Chen, Tung-Hung Su, Hiromitsu Kumada, Wan-Ting Yang, Hung-Chih Yang, Chen-Hua Liu, Pei-Jer Chen, Hwai-I. Yang, Jia-Horng Kao
  Hepatology.2025;[Epub]     CrossRef
• Cost‐Effectiveness of Antiviral Therapy in Patients With High Viremic Indeterminate Phase Chronic Hepatitis B
  Suk‐Chan Jang, Won‐Mook Choi, Gi‐Ae Kim, Gwang Hyeon Choi, Yun Bin Lee, Dong Hyun Sinn, Hye‐Lin Kim, Young‐Suk Lim
  Liver International.2025;[Epub]     CrossRef
• Comparison of the efficacy and action mechanism of Chinese patent medicines for liver fibrosis and cirrhosis
  Lingping Fu, Jin Xie, ZeXin Wang, Tao Jiang, Yi Zeng, Jing Yan, Rong Sun, Mengshuang Huang, Shengyi Du, Xiaobao Wang, Yuyang Liu, Kailai Xi, Ailin Chen, Xiao Ma, Jinhao Zeng, Thomas Efferth
  Phytomedicine.2025; 148: 157246.     CrossRef
• Longitudinal observation of chronic domestic cat hepadnavirus infection in cats with evidence of extrahepatic involvement
  Sabrina Wahyu Wardhani, Sitthichok Lacharoje, Tanit Kasantikul, Chutchai Piewbang, Somporn Techangamsuwan
  Journal of Feline Medicine and Surgery.2025;[Epub]     CrossRef
• Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?
  Yen-Chun Liu, Wen-Juei Jeng
  Current Hepatology Reports.2024; 23(1): 11.     CrossRef
• Stat3 activation-triggered transcriptional networks govern the early stage of HBV-induced hepatic inflammation
  Jinglin Tang, Jiaxuan Zhang, Gaoli Zhang, Wenhui Peng, Ning Ling, Yingzhi Zhou, Hongmei Xu, Hong Ren, Min Chen, Marthandan Mahalingam, Swati Jain
  mBio.2024;[Epub]     CrossRef
• Noninvasive Models to Assess Liver Inflammation and Fibrosis in Chronic HBV Infected Patients with Normal or Mildly Elevated Alanine Transaminase Levels: Which One Is Most Suitable?
  Shasha Ma, Lian Zhou, Shutao Lin, Mingna Li, Jing Luo, Lubiao Chen
  Diagnostics.2024; 14(5): 456.     CrossRef
• Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis
  Hyunjae Shin, Won-Mook Choi, Seung Up Kim, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Fabien Zoulim
  JHEP Reports.2024; 6(7): 101089.     CrossRef
• Inverse relationship between HBV DNA levels and liver histopathological changes in immune‐tolerant CHB patients
  Deliang Huang, Huiyi Lai, Zhibin Zhu, Hong Yu, Jinghan Peng, Yuanyuan Chen, Xuejiao Liao, Jun Chen
  Journal of Viral Hepatitis.2024; 31(7): 363.     CrossRef
• Editorial: High qHBsAg—is it a good or bad signal?
  Beom Kyung Kim
  Alimentary Pharmacology & Therapeutics.2024; 59(12): 1616.     CrossRef
• Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase
  Jian Wang, Li Zhu, Zhiyi Zhang, Shaoqiu Zhang, Yifan Pan, Yuanyuan Li, Fei Cao, Chao Jiang, Tao Fan, Ye Xiong, Jiacheng Liu, Yuxin Chen, Shengxia Yin, Xin Tong, Chuanwu Zhu, Xingxiang Liu, Jie Li, Chao Wu, Rui Huang
  Virology Journal.2024;[Epub]     CrossRef
• Estimating the key outcomes and hepatocellular carcinoma risk in patients in immune‐tolerant phase of chronic hepatitis B virus infection: A systematic review and meta‐analysis
  Min Liu, Taixue Zhao, Jinyang Zhang, Bing Bu, Ruyi Zhang, Xueshan Xia, Jiawei Geng
  Reviews in Medical Virology.2024;[Epub]     CrossRef
• Significant liver histological change is common in HBeAg-positive chronic hepatitis B with normal ALT
  Menghui Duan, Huanming Xiao, Meijie Shi, Yubao Xie, Pengtao Zhao, Sheng Li, Xiaoling Chi, Xueen Liu, Hui Zhuang
  BMC Infectious Diseases.2024;[Epub]     CrossRef
• Preface
  Seung Up Kim
  Clinical and Molecular Hepatology.2024; 30(Suppl): S3.     CrossRef
• Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis
  Mi Na Kim, Jihyun An, Eun Hwa Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Young-Joo Jin, Young Eun Chon, Seung Up Kim, Dae Won Jun, Ji Won Han, Miyoung Choi
  Clinical and Molecular Hepatology.2024; 30(Suppl): S106.     CrossRef
• HBeAg-positive CHB patients with indeterminate phase associated with a high risk of significant fibrosis
  Yuanyuan Li, Yijia Zhu, Dongmei Gao, Yifan Pan, Jian Wang, Shaoqiu Zhang, Xiaomin Yan, Li Zhu, Chuanwu Zhu, Xingxiang Liu, Zhaoping Zhang, Jie Li, Yuxin Chen, Rui Huang, Chao Wu
  Virology Journal.2024;[Epub]     CrossRef
• Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
  Joo Hyun Oh, Dong Hyun Sinn
  Clinical and Molecular Hepatology.2023; 29(2): 367.     CrossRef
• Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”
  Chia-Ming Chu, Yun-Fan Liaw
  Clinical and Molecular Hepatology.2023; 29(2): 510.     CrossRef
• The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
  Moon Haeng Hur, Jeong-Hoon Lee
  Clinical and Molecular Hepatology.2023; 29(2): 363.     CrossRef
• Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
  Jeong-Ju Yoo, Sang Gyune Kim
  Clinical and Molecular Hepatology.2023; 29(2): 513.     CrossRef
• Research Progress in Histological Features and Related Influencing Factors of Chronic Hepatitis B Patients with Persistent Normal ALT
  宇行 刘
  Advances in Clinical Medicine.2023; 13(05): 8702.     CrossRef
• Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
  Chang Hun Lee, Gwang Hyeon Choi, Hwa Young Choi, Sojung Han, Eun Sun Jang, Young Eun Chon, Young Chang, Kyung-Ah Kim, Do Young Kim, Hyung Joon Yim, Hye-Lin Kim, Sook-Hyang Jeong, In Hee Kim
  Clinical and Molecular Hepatology.2023; 29(3): 779.     CrossRef
• HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
  Soon Kyu Lee, Jung Hyun Kwon
  Clinical and Molecular Hepatology.2023; 29(3): 825.     CrossRef

Citations

Citations to this article as recorded by  

• An electroneutral fluorescent probe for visualization of lipid droplets polarity heterogeneity and NAFLD detection
  Zhengshuai Wu, Fei Gao, Shuyu Wang, Mengqi Yan, Shuxian Cao, Junjun Liu, Xinyue Li, Guoxia Liu, Sumei Lu, Xuechen Li
  Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2026; 346: 126842.     CrossRef
• Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study
  Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, Juyeon Oh, Beom Kyung Kim, Jin-Ha Yoon
  American Journal of Gastroenterology.2025; 120(2): 410.     CrossRef
• Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase
  Md Asrarul Islam, Rhema Khairnar, Joshua Fleishman, Sandra E. Reznik, Louis Ragolia, Shruthi Gobbooru, Sunil Kumar
  Molecular and Cellular Endocrinology.2025; 595: 112404.     CrossRef
• Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
  Swasthika Gurjar, Ramanarayana Bhat A, Raghavendra Upadhya, Revathi P. Shenoy
  Lipids in Health and Disease.2025;[Epub]     CrossRef
• Do Child–Turcotte–Pugh and nutritional assessments predict survival in cirrhosis: A longitudinal study
  Randhall B Carteri, Claudio A Marroni, Luis F Ferreira, Letícia P Pinto, Juliana Czermainski, Cristiane V Tovo, Sabrina A Fernandes
  World Journal of Hepatology.2025;[Epub]     CrossRef
• Unraveling the molecular mechanisms of Fufangduzhong formula in alleviating high-fat diet-induced non-alcoholic fatty liver disease in mice
  Yu Mou, Yao Tang, Xiuyan Zheng, Xiang Liu, Xuemei Wu, Hongji Wang, Jie Zeng, Qing Rao, Yaacov Ben-David, Yanmei Li, Lei Huang
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Elevated red blood cell folate levels are associated with metabolic dysfunction-associated steatotic liver disease: results from NHANES 2017–2020
  Xin Liao, Song Yu, Lin Wang, Ruyue Zhang, Ke Yu
  Frontiers in Physiology.2025;[Epub]     CrossRef
• Investigating the Effects of Gossypetin on Liver Health in Diet-Induced Pre-Diabetic Male Sprague Dawley Rats
  Karishma Naidoo, Andile Khathi
  Molecules.2025; 30(8): 1834.     CrossRef
• Prospective Comparison of 2D-Shear Wave Elastography and Vibration-Controlled Transient Elastography in Assessing Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
  Qingxin Li, Yanhang Gao, Dongxuan Wang, Xiaoxue Zhu, Jing Jia, Lili Liu, Huining Tian, Lishuang Wang, Yingwen Zhang, Dezhi Zhang
  Academic Radiology.2025; 32(9): 5100.     CrossRef
• Alisol B alleviates MASLD by activating liver autophagy and fatty acid oxidation via Ces2a
  Congcong Zhang, Lin Chen, Yuwei Jiang, Jiannan Qiu, Yiyou Lin, Guilin Ren, Fangying Xu, Jiale Xi, Zhiling Yu, Xianglu Rong, Xiaobing Dou
  International Immunopharmacology.2025; 157: 114768.     CrossRef
• Multiple machine learning algorithms identify 13 types of cell death-critical genes in large and multiple non-alcoholic steatohepatitis cohorts
  Renao Jiang, Longfei Dai, Xinjian Xu, Zhen Zhang
  Lipids in Health and Disease.2025;[Epub]     CrossRef
• Therapeutic potential of Glycyrrhiza glabra L. extract and atorvastatin in HFD-induced MAFLD: in vitro and in vivo exploration
  Saumya Rastogi, Vishwajeet Bachhar, Vibha Joshi, Sanjay Kumar, Dharamveer Panjwani, Lakhveer Singh, Rajesh Haldhar
  3 Biotech.2025;[Epub]     CrossRef
• A new diphenylmethanone from Rumex crispus L. ameliorates sodium palmitate-oleate induced steatosis in HepG2 cells
  Wen-Yao Zou, Zheng-Hong Guo, Shuai Dou, Ting Xiao, Wu-de Yang
  Natural Product Research.2025; : 1.     CrossRef
• Efficacy of interventions with live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules in metabolic associated fatty liver disease patients: a meta-analysis of randomized controlled trials
  Yutong Wu, Hao Wu, Hang Yi
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Deep learning-based method for grading histopathological liver fibrosis in rodent models of metabolic dysfunction-associated steatohepatitis
  Soo Min Ko, Jae-ik Shin, Yiyu Hong, Hyunji Kim, Insuk Sohn, Ji-Young Lee, Hyo-Jeong Han, Da Som Jeong, Yerin Lee, Woo-Chan Son
  Frontiers in Medicine.2025;[Epub]     CrossRef
• КЛІНІКО-МОРФОЛОГІЧНІ АСПЕКТИ ПЕРВИННОГО НЕАЛКОГОЛЬНОГО СТЕАТОГЕПАТИТУ ЗА НАЯВНОСТІ КОМОРБІДНОЇ ПАТОЛОГІЇ ЖОВЧНОГО МІХУРА
  О. Ю. Фофанова, В. В. Феденько, З. Я. Гурик, Е. О. Кіндратів, І. Г. Лаб'як
  Art of Medicine.2025; : 113.     CrossRef
• Calycosin-7-O-β-D-glucoside alleviates nonalcoholic fatty liver disease by regulating short-chain fatty acids metabolism and metabolic regulators
  Yanping Zeng, Xinrun Huang, Yuci Ma, Xiaodie Di, Zhao Li, Hebin Wang, Xiaodong Wei
  The Journal of Nutritional Biochemistry.2025; 145: 110018.     CrossRef
• Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia
  Edomias Adyamseged Berhe, Rediet Ambachew Sema, Yididya Mehari Tesfaye, Abel Andargie Berhane, Mikale Dawit, Ephrem Mamo Gebrehiwot, Subah Abderehim Yesuf, Balamurugan Ramatchandirin
  Journal of Diabetes Research.2025;[Epub]     CrossRef
• Automated Detection of Non‐Alcoholic Fatty Liver Disease Using Histopathological Images: A Systematic Review
  Hamed Zamanian, Ahmad Shalbaf, Maryam Parvizi, Roohallah Alizadehsani, Ru‐San Tan, U. Rajendra Acharya
  WIREs Data Mining and Knowledge Discovery.2025;[Epub]     CrossRef
• Polarity Prompting Vision Foundation Models for Pathology Image Analysis
  Chong Yin, Siqi Liu, Kaiyang Zhou, Vincent Wai-Sun Wong, Pong C. Yuen
  IEEE Transactions on Medical Imaging.2025; 44(11): 4579.     CrossRef
• Clinical Profile of Psoriasis Patients With Comorbid Fatty Liver and Risk Factors for Advanced Liver Fibrosis in Those With Metabolic Dysfunction–Associated Steatotic Liver Disease
  Hidenori Watabe, Tomomitsu Miyagaki, Kaori Nakajima, Ken Go, Tatsuro Okano, Takafumi Kadono
  The Journal of Dermatology.2025;[Epub]     CrossRef
• Matcha mitigates metabolic and inflammatory disturbances induced by high-fat-sucrose diets in rats
  Nourhan M. Abd El-Aziz, Marwa R. Elbakatoshy, Ebtehal A. Farrage, Oscar Zannou, Reza Tahergorabi, Ayman M. Khalifah, Majid Aminzare, Mohamed G. Shehata
  Journal of Functional Foods.2025; 135: 107112.     CrossRef
• Metabolic Dysfunction-Associated Steatohepatitis in Focus: Pathogenesis, Non-Invasive Diagnostics, and Future Approaches
  Abdulrahman Ismaiel, Mhd Bashir Almonajjed, Cristina Sorina Catana, Stefan-Lucian Popa, Dan L. Dumitrascu
  Archives of Medical Research.2025; 56(8): 103350.     CrossRef
• Association of Stroke With Metabolic Dysfunction–Associated Fatty Liver Disease With and Without CKD
  Yuhao Li, Shouling Wu, Jingli Gao, Yijun Zhang, Yingting Zuo, Xue Tian, Shuohua Chen, Aijun Xing, Anxin Wang, Yan He
  American Journal of Kidney Diseases.2024; 83(4): 477.     CrossRef
• Sex-specific differences in ectopic fat and metabolic characteristics of paediatric nonalcoholic fatty liver disease
  Eun Hye Lee, Ji Young Kim, Hye Ran Yang
  International Journal of Obesity.2024; 48(4): 486.     CrossRef
• Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review)
  Junmin Wang, Jiacheng Li, Yugang Fu, Yingying Zhu, Liubing Lin, Yong Li
  International Journal of Molecular Medicine.2024;[Epub]     CrossRef
• Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
  Sang Yi Moon, Yang Hyun Baek, Se Young Jang, Dae Won Jun, Ki Tae Yoon, Young Youn Cho, Hoon Gil Jo, Ae Jeong Jo
  Gut and Liver.2024; 18(2): 283.     CrossRef
• Lipid droplet detection in histopathological images using reinforcement learning
  Yoshitomi Harada, Haruto Nishida, Keiko Matsuura
  Biotechnology & Biotechnological Equipment.2024;[Epub]     CrossRef
• Evaluating the relative importance of different blood pressure indices in screening for NAFLD: a survey report based on a health examination population
  Chong Hu, Ziqi Yu, Changli Wei, Guotai Sheng, Jianyong Chen, Yang Zou
  Frontiers in Cardiovascular Medicine.2024;[Epub]     CrossRef
• Perilipins: A family of five fat‐droplet storing proteins that play a significant role in fat homeostasis
  Preethi Chandrasekaran, Sabine Weiskirchen, Ralf Weiskirchen
  Journal of Cellular Biochemistry.2024;[Epub]     CrossRef
• A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice
  Rose A. Willett, Volodymyr P. Tryndyak, Jennifer M. Hughes Hanks, Lana Elkins, Suresh K. Nagumalli, Mark I. Avigan, Sharon A. Ross, Gonçalo Gamboa da Costa, Frederick A. Beland, Ivan Rusyn, Igor P. Pogribny
  Toxicology and Applied Pharmacology.2024; 491: 117046.     CrossRef
• A peptide alleviated oxidative damages in the L02 cells and mice liver
  Gan Gao, Zhiyang Zhang, Qiheng Wang, Zhihui Xie, Bing Liu, Hongliang Huang
  Biochemical and Biophysical Research Communications.2024; 734: 150643.     CrossRef
• Targeting long non-coding RNA H19 as a therapeutic strategy for liver disease
  Yulan Shi, Fenghua Qu, Shiyun Zeng, Xinchen Wang, Yuting Liu, Qirui Zhang, Ding Yuan, Chengfu Yuan
  Progress in Biophysics and Molecular Biology.2024; 194: 1.     CrossRef
• Transcription factor ETV4 plays a critical role in the development of non-alcoholic fatty liver disease
  Bhavani Gadiraju, Jhansi Magisetty, Vijay Kondreddy
  International Journal of Biological Macromolecules.2024; 282: 137235.     CrossRef
• Arctium lappa L. Extract Alleviates Non-Alcoholic Fatty Liver Injury in Mices
  娜 李
  Hans Journal of Medicinal Chemistry.2024; 12(04): 309.     CrossRef
• Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
  Jaehyun Bae, Eugene Han, Hye Won Lee, Cheol-Young Park, Choon Hee Chung, Dae Ho Lee, Eun-Hee Cho, Eun-Jung Rhee, Ji Hee Yu, Ji Hyun Park, Ji-Cheol Bae, Jung Hwan Park, Kyung Mook Choi, Kyung-Soo Kim, Mi Hae Seo, Minyoung Lee, Nan-Hee Kim, So Hun Kim, Won-
  Diabetes & Metabolism Journal.2024; 48(6): 1015.     CrossRef
• Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology
  Yu-Jin Zhu, Yan Zhang, Yao Rao, Yong Jiang, Yong-Gang Liu, Jian-Zhou Li, Jia-Qi Yuan, Ying Zhao, Wen-Wen Zheng, Lin Ma, Chun-Yan Wang, Jia Li
  World Journal of Hepatology.2024; 16(12): 1407.     CrossRef
• Gut microbiome and nonalcoholic fatty liver disease
  Meng-Yuan Wu, Jian-Gao Fan
  Hepatobiliary & Pancreatic Diseases International.2023; 22(5): 444.     CrossRef

Citations

Citations to this article as recorded by  

• Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis
  Gina Ryu, Eileen Laurel Yoon, Wankyu Kim, Dae Won Jun
  Diagnostics.2025; 15(3): 342.     CrossRef
• New clinical trial design in precision medicine: discovery, development and direction
  Xiao-Peng Duan, Bao-Dong Qin, Xiao-Dong Jiao, Ke Liu, Zhan Wang, Yuan-Sheng Zang
  Signal Transduction and Targeted Therapy.2024;[Epub]     CrossRef
• Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
  Eun Jeoung Lee, Seung Min Lee, Ju Hee Oh, Hye Young Kim, Waqar Khalid Saeed, Hyun Sung Kim, Dae Won Jun
  Nutrients.2024; 16(7): 920.     CrossRef
• Discovery of Nine Dipeptidyl Peptidase-4 Inhibitors from Coptis chinensis Using Virtual Screening, Bioactivity Evaluation, and Binding Studies
  Zixi Zhao, Ruonan Ma, Yuqing Ma, Liqiang Zhao, Lele Wang, Yuzhen Fang, Yuxin Zhang, Xia Wu, Xing Wang
  Molecules.2024; 29(10): 2304.     CrossRef
• DPP-IV as a potential candidate in anti-obesity and obesity-related diseases treatment
  Xin Guo, Huolun Feng, Liyang Cai, Jiabin Zheng, Yong Li
  Biomedicine & Pharmacotherapy.2024; 180: 117464.     CrossRef
• From NAFLD to HCC: Advances in noninvasive diagnosis
  Qinchen Xu, Maoxiao Feng, Yidan Ren, Xiaoyan Liu, Huiru Gao, Zigan Li, Xin Su, Qin Wang, Yunshan Wang
  Biomedicine & Pharmacotherapy.2023; 165: 115028.     CrossRef
• SGLT-2 Inhibitors for Non-Alcoholic Fatty Liver Disease: A Review
  Rong Xu, Difei Lian, Yan Xie, Zhilei Chen, Yan Wang, Lin Mu, Yuan Wang, Baoyu Zhang
  Frontiers in Bioscience-Landmark.2023;[Epub]     CrossRef
• Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials
  Joel Yeh Siang Chen, Damien Chua, Carissa Odelia Lim, Wan Xi Ho, Nguan Soon Tan
  International Journal of Molecular Sciences.2022; 24(1): 158.     CrossRef

Citations

Citations to this article as recorded by  

• The utility of next‐generation sequencing in challenging liver FNA biopsies
  Dana J. Balitzer, Nancy Y. Greenland
  Cancer Cytopathology.2024; 132(11): 714.     CrossRef
• Laser tweezer Raman spectroscopy combined with deep neural networks for identification of liver cancer cells
  Weng Shuyun, Fengjie Lin, Changbin Pan, Qiyi Zhang, Hong Tao, Min Fan, Luyun Xu, Kien Voon Kong, Yuanmei Chen, Duo Lin, Shangyuan Feng
  Talanta.2023; 264: 124753.     CrossRef

Citations

Citations to this article as recorded by  

• Role of imaging-guided biopsy for hepatocellular carcinoma
  Roberto Cannella, Zachary T. Berman, Nikhil V. Tirukkovalur, Samer T. Tohme, Marta I. Minervini, Alessandro Furlan
  European Journal of Radiology.2025; 191: 112271.     CrossRef
• Novel and less invasive biomarker assays to measure liver ATP7B in Wilson disease patients
  Rosanna J. Jiang, Lucy Chen, Kimberly Amburgey, Danie P. M. La, Brodie Fischbacher, Erle M. Holgersen, Lucienne Ronco, Adam J. Gehring, Jordan J. Feld, Kahlin Cheung-Ong
  Scientific Reports.2025;[Epub]     CrossRef
• Combined fine needle aspiration cytology and core needle biopsy in the same setting: A two‐years’ experience
  Valeria Ciliberti, Elisabetta Maffei, Angela D'Ardia, Francesco Sabbatino, Bianca Serio, Antonio D'Antonio, Pio Zeppa, Alessandro Caputo
  Cytopathology.2024; 35(1): 78.     CrossRef
• Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients
  Danial Khorsandi, Jia‐Wei Yang, Samuel Foster, Safoora Khosravi, Negar Hosseinzadeh Kouchehbaghi, Fahimeh Zarei, Yun Bin Lee, Farhana Runa, Ankit Gangrade, Leon Voskanian, Darbaz Adnan, Yangzhi Zhu, Zhaohui Wang, Vadim Jucaud, Mehmet Remzi Dokmeci, Xiling
  Advanced Healthcare Materials.2024;[Epub]     CrossRef
• Risk factors of non-diagnostic percutaneous liver tumor biopsy: a single-center retrospective analysis of 938 biopsies based on cause of error
  Shintaro Kimura, Miyuki Sone, Shunsuke Sugawara, Chihiro Itou, Takumi Oshima, Mizuki Ozawa, Rakuhei Nakama, Sho Murakami, Yoshiyuki Matsui, Yasuaki Arai, Masahiko Kusumoto
  Japanese Journal of Radiology.2024;[Epub]     CrossRef
• Usefulness of on‐site cytology of liver tumor biopsy in specimen sampling for cancer genomic profiling test
  Tasuku Nakabori, Yutaro Abe, Sena Higashi, Kaori Mukai, Risa Yoshioka, Yuki Morimoto, Yuki Koyanagi, Satoshi Tanada, Shigenori Nagata, Keiichiro Honma, Kazuyoshi Ohkawa
  Cancer Medicine.2023; 12(7): 7888.     CrossRef
• Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues
  Violetta Rosiek, Ksenia Janas, Beata Kos-Kudła
  Biomedicines.2023; 11(3): 842.     CrossRef
• Sensitivity of cytology in liver tumor biopsy and its significance in the prompt clinical diagnosis of non‐hepatocellular carcinoma
  Tasuku Nakabori, Yutaro Abe, Sena Higashi, Kaori Mukai, Azusa Shingetsu, Sanako Nishimura, Sayoko Tsuzaki, Ayumi Ryu, Satoshi Tanada, Shigenori Nagata, Keiichiro Honma, Kazuyoshi Ohkawa
  Cancer Medicine.2023; 12(11): 12336.     CrossRef
• Cytological diagnosis of metastatic liver carcinomas
  S.V. Smetanina, E.N. Slavnova, E.Yu. Uskova, N.Yu. Orlinskaya, M.B. Danyaeva, A.A. Khusiyanova
  P.A. Herzen Journal of Oncology.2023; 12(3): 27.     CrossRef
• Refining Liver Biopsy in Hepatocellular Carcinoma: An In-Depth Exploration of Shifting Diagnostic and Therapeutic Applications
  Zeno Spârchez, Rareș Crăciun, Iuliana Nenu, Lavinia Patricia Mocan, Mihaela Spârchez, Tudor Mocan
  Biomedicines.2023; 11(8): 2324.     CrossRef
• Reliability of combined fine needle aspiration and core needle biopsies in the diagnosis of liver lesions: An 8‐year institutional experience
  Yuan Shen, Evgeniya Angelova, Mariana Moreno Prats, Cecilia Clement, Vicki Schnadig, Heather Stevenson‐Lerner, Jing He
  Cytopathology.2022; 33(4): 472.     CrossRef
• Image-guided Percutaneous Biopsy of the Liver
  Ather Adnan, Rahul A. Sheth
  Techniques in Vascular and Interventional Radiology.2021; 24(4): 100773.     CrossRef
• Touch Imprint Intraoperative Flow Cytometry as a Complementary Tool for Detailed Assessment of Resection Margins and Tumor Biology in Liver Surgery for Primary and Metastatic Liver Neoplasms
  Georgios Markopoulos, Georgios Glantzounis, Anna Goussia, Georgios Lianos, Anastasia Karampa, George Alexiou, George Vartholomatos
  Methods and Protocols.2021; 4(3): 66.     CrossRef
• Biopsy or cytology for diagnosing hepatic focal lesions?
  Haeryoung Kim
  Clinical and Molecular Hepatology.2021; 27(2): 278.     CrossRef

Citations

Citations to this article as recorded by  

• Quantitative fibrosis identifies biliary tract involvement and is associated with outcomes in pediatric autoimmune liver disease
  Leticia Khendek, Cyd Castro-Rojas, Constance Nelson, Mosab Alquraish, Rebekah Karns, Jennifer Kasten, Xiao Teng, Alexander G. Miethke, Amy E. Taylor
  Hepatology Communications.2025;[Epub]     CrossRef
• A comparative study on the effect of melatonin and orlistat combination versus orlistat alone on high fat diet-induced hepatic changes in the adult male albino rats (a histological and morphometric study)
  Sayed M. El-Sayed, Gehan A. El-Sayed, Mansour M.A, Enas Haridy Ahmed, Sherif A. Kamar
  Ultrastructural Pathology.2025; 49(1): 20.     CrossRef
• Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care
  Nicola Pugliese, Arianna Bertazzoni, Cesare Hassan, Jörn M. Schattenberg, Alessio Aghemo
  Cancers.2025; 17(5): 722.     CrossRef
• Extracellular Matrix Microstructures Modulate Hepatic Methionine Cycle and Methylations
  John A. Terrell, Chengpeng Chen
  Biomacromolecules.2025; 26(6): 3356.     CrossRef
• Assessing the diagnostic accuracy of ChatGPT-4 in the histopathological evaluation of liver fibrosis in MASH
  Davide Panzeri, Thiyaphat Laohawetwanit, Reha Akpinar, Camilla De Carlo, Vincenzo Belsito, Luigi Terracciano, Alessio Aghemo, Nicola Pugliese, Giuseppe Chirico, Donato Inverso, Julien Calderaro, Laura Sironi, Luca Di Tommaso
  Hepatology Communications.2025;[Epub]     CrossRef
• Phosphocreatine alleviates liver fibrosis in diabetic mice by targeting TGF-β/Smad and α-SMA pathways
  Fu Han Wang, Eskandar Qaed, Waleed Aldahmash, Mueataz A. Mahyoub, Dalal Sanad Al-Mutairi, Zeyao Tang, Marwan almoiliqy
  Tissue and Cell.2025; 96: 103013.     CrossRef
• Proof of Concept: Super‐Resolution Ultrasound and Viscoelastic Imaging of Hepatic Microcirculation for Early Detection and Staging of Liver Fibrosis in a Murine Model
  Rui Zhang, Jieqiong Wang, Tingting Liu, Yan Wang, Shuai Yang, Fei Yan, Li Xue
  Journal of Ultrasound in Medicine.2025; 44(8): 1481.     CrossRef
• Leveraging artificial intelligence to validate traditional biomarkers and drug targets in liver cancer recovery: a mini review
  Shengjian Wu, Xiaoqiao Chen, Yuxiu Ji, Chi Zhang, Yujie Xie, Bin Liang
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Emerging role of artificial intelligence in gastroenterology and hepatology
  Umid K Shrestha
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• The prediction of liver decompensation using hepatic collagen deposition assessed by computer-assisted image analysis with Masson’s trichrome stain
  Hae Won Yoo, Jae Woo Park, Min Jung Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Scandinavian Journal of Gastroenterology.2024; 59(1): 85.     CrossRef
• Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions
  Vlad Ratziu, Marcus Hompesch, Mathieu Petitjean, Cindy Serdjebi, Janani S. Iyer, Anil V. Parwani, Dean Tai, Elisabetta Bugianesi, Kenneth Cusi, Scott L. Friedman, Eric Lawitz, Manuel Romero-Gómez, Detlef Schuppan, Rohit Loomba, Valérie Paradis, Cynthia Be
  Journal of Hepatology.2024; 80(2): 335.     CrossRef
• AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response
  Feng Liu, Yameng Sun, Dean Tai, Yayun Ren, Elaine L. K. Chng, Aileen Wee, Pierre Bedossa, Rui Huang, Jian Wang, Lai Wei, Hong You, Huiying Rao
  Diagnostics.2024; 14(16): 1837.     CrossRef
• Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model
  Radina Kostadinova, Simon Ströbel, Li Chen, Katia Fiaschetti‑Egli, Jana Gadient, Agnieszka Pawlowska, Louis Petitjean, Manuela Bieri, Eva Thoma, Mathieu Petitjean
  Scientific Reports.2024;[Epub]     CrossRef
• Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities
  Eugene Han, Yong-ho Lee, Sang Hoon Ahn, Bong-Soo Cha, Seung Up Kim, Byung-Wan Lee
  Gut and Liver.2024; 18(3): 509.     CrossRef
• Potential role of predictive models in assessment of liver inflammation in patients with hepatocellular carcinoma: a two-center cohort study
  Wei Xu, Bolun Li, Huai Gong, Jingdong Li, Zhanwei Yang, Yu Liu
  European Journal of Medical Research.2024;[Epub]     CrossRef
• NAFLD, MAFLD and obesity: brothers in arms?
  Mariana Verdelho Machado, Helena Cortez-Pinto
  Nature Reviews Gastroenterology & Hepatology.2023; 20(2): 67.     CrossRef
• Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis
  Heechul Nam, Jeong-Ju Yoo, Yuri Cho, Seong Hee Kang, Sang Bong Ahn, Hye-Won Lee, Dae Won Jun, Do Seon Song, Miyoung Choi
  Digestive and Liver Disease.2023; 55(9): 1178.     CrossRef
• Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
  Seung Min Lee, Dae Won Jun
  Clinical and Molecular Hepatology.2023; 29(1): 171.     CrossRef
• Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial
  Arun J. Sanyal, Patricia Lopez, Eric J. Lawitz, Kathryn J. Lucas, Juergen Loeffler, Won Kim, George B. B. Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H. Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M. Sheikh, John
  Nature Medicine.2023; 29(2): 392.     CrossRef
• Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
  Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne
  Clinical and Molecular Hepatology.2023; 29(Suppl): S157.     CrossRef
• Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
  Jung Hwan Yu, Han Ah Lee, Seung Up Kim
  Clinical and Molecular Hepatology.2023; 29(Suppl): S136.     CrossRef
• Screening strategy for non-alcoholic fatty liver disease
  Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
  Clinical and Molecular Hepatology.2023; 29(Suppl): S103.     CrossRef
• Non-alcoholic fatty liver disease: Definition and subtypes
  Seul Ki Han, Soon Koo Baik, Moon Young Kim
  Clinical and Molecular Hepatology.2023; 29(Suppl): S5.     CrossRef
• Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
  Terry Cheuk-Fung Yip, Fei Lyu, Huapeng Lin, Guanlin Li, Pong-Chi Yuen, Vincent Wai-Sun Wong, Grace Lai-Hung Wong
  Clinical and Molecular Hepatology.2023; 29(Suppl): S171.     CrossRef
• Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
  Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato
  Computational and Structural Biotechnology Journal.2023; 21: 2495.     CrossRef
• Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI‐PDFF in NAFLD
  Beom K. Kim, Nicole Bernstein, Daniel Q. Huang, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajim
  Alimentary Pharmacology & Therapeutics.2023; 58(2): 229.     CrossRef
• Diagnóstico, tratamiento y complicaciones actualizadas de la enfermedad de hígado graso no alcohólico
  Nicole Estefanía Rivadeneira Poveda, Verónica Cristina Jurado Melo
  Anatomía Digital.2023; 6(1.2): 6.     CrossRef
• Artifacts in two-dimensional shear wave elastography of liver
  Hui-Peng Wang, Peng-Chao Zheng, Xue-Mei Wang, Liang Sang
  World Journal of Gastroenterology.2023; 29(21): 3318.     CrossRef
• Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD
  Yun Kyu Lee, Bo Kyung Koo, Sae Kyung Joo, Dong Hyeon Lee, Heejoon Jang, Jee Won Chai, Myoung Seok Lee, Si Won Jang, Young Ho So, Jeong Hwan Park, Mee Soo Chang, Won Kim
  Alimentary Pharmacology & Therapeutics.2023; 58(3): 322.     CrossRef
• Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
  Jung Wook Seo, Youe Ree Kim, Jong Keon Jang, So Yeon Kim, Young Youn Cho, Eun Sun Lee, Dong Ho Lee
  Ultrasonography.2023; 42(3): 421.     CrossRef
• AutoFibroNet: A deep learning and multi‐photon microscopy‐derived automated network for liver fibrosis quantification in MAFLD
  Huiling Zhan, Siyu Chen, Feng Gao, Guangxing Wang, Sui‐Dan Chen, Gangqin Xi, Hai‐Yang Yuan, Xiaolu Li, Wen‐Yue Liu, Christopher D. Byrne, Giovanni Targher, Miao‐Yang Chen, Yong‐Feng Yang, Jun Chen, Zhiwen Fan, Xitai Sun, Guorong Cai, Ming‐Hua Zheng, Shuan
  Alimentary Pharmacology & Therapeutics.2023; 58(6): 573.     CrossRef
• Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
  Tae Seop Lim, Ho Soo Chun, Soon Sun Kim, Ja Kyung Kim, Minjong Lee, Hyo Jung Cho, Seung Up Kim, Jae Youn Cheong
  Gut and Liver.2023; 17(4): 610.     CrossRef
• Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients
  Mi Na Kim, Kyungdo Han, Juhwan Yoo, Seong Gyu Hwang, Xuehong Zhang, Sang Hoon Ahn
  International Journal of Cancer.2023; 153(8): 1448.     CrossRef
• Serum IL-27 levels increase in subjects with hypothyroidism and are negatively correlated with the occurrence of nonalcoholic fatty liver disease
  Yahui Wen, Heng Zhang, Ning Yang, Xia Gao, Zhe Chen, Jia Liu, Guang Wang
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study
  Beom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem K. Oz, Ayse Erden, Emily Truong, Ju Dong Yang, Mazen Noureddin, Alina M. Allen, Rohit Loomba, Veeral Ajmera
  Hepatology.2023; 78(6): 1858.     CrossRef
• Diagnosis of liver fibrosis using digital analysis
  Anna Kleczka, Bogdan Mazur, Krzysztof Tomaszek, Radosław Dzik, Agata Kabała-Dzik
  Diagnostyka Laboratoryjna.2023; 59(2): 65.     CrossRef
• Noninvasive surrogates are poor predictors of liver fibrosis in patients with Fontan circulation
  Yu Rim Shin, Seung Up Kim, Sak Lee, Jae Young Choi, Han Ki Park, Jeong Eun Yoo, Young Nyun Park
  The Journal of Thoracic and Cardiovascular Surgery.2022; 164(4): 1176.     CrossRef
• Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
  Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jae Young Jang, Soo Young Park, Hyun Woong Lee, Chun Kyon Lee, Seung Up Kim
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH
  Nikolai V. Naoumov, Dominique Brees, Juergen Loeffler, Elaine Chng, Yayun Ren, Patricia Lopez, Dean Tai, Sophie Lamle, Arun J. Sanyal
  Journal of Hepatology.2022; 77(5): 1399.     CrossRef
• The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
  Haofei Hu, Yong Han, Changchun Cao, Yongcheng He
  Journal of Translational Medicine.2022;[Epub]     CrossRef
• Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
  Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Tuo Lin, Xin M. Tu, Jaclyn Bergstrom, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi N
  Journal of Hepatology.2022; 77(6): 1482.     CrossRef
• Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease
  Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim
  Abdominal Radiology.2022; 47(11): 3733.     CrossRef
• Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study
  Wei Xu, Bolun Li, Zhanwei Yang, Jingdong Li, Fei Liu, Yu Liu
  Journal of Hepatocellular Carcinoma.2022; Volume 9: 751.     CrossRef
• Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
  Ludovico Abenavoli, Tiziana Larussa, Alessandro Corea, Anna Caterina Procopio, Luigi Boccuto, Marcello Dallio, Alessandro Federico, Francesco Luzza
  Nutrients.2021; 13(2): 494.     CrossRef
• The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics
  James Neuberger, Owen Cain
  Hepatic Medicine: Evidence and Research.2021; Volume 13: 59.     CrossRef
• Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
  Hee Kyung Shin, Jeong Hwan Park, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee, Won Kim
  Scientific Reports.2021;[Epub]     CrossRef
• Predict Early Recurrence of Resectable Hepatocellular Carcinoma Using Multi-Dimensional Artificial Intelligence Analysis of Liver Fibrosis
  I-Ting Liu, Chia-Sheng Yen, Wen-Lung Wang, Hung-Wen Tsai, Chang-Yao Chu, Ming-Yu Chang, Ya-Fu Hou, Chia-Jui Yen
  Cancers.2021; 13(21): 5323.     CrossRef
• Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring
  Michael J. Nash, Evgenia Dobrinskikh, Sean A. Newsom, Ilhem Messaoudi, Rachel C. Janssen, Kjersti M. Aagaard, Carrie E. McCurdy, Maureen Gannon, Paul Kievit, Jacob E. Friedman, Stephanie R. Wesolowski
  JCI Insight.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Value of Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) in Assessing Liver Fibrosis in Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Review of its Serum Biomarker Role
  Mohammadjavad Sotoudeheian
  Current Protein & Peptide Science.2025; 26(1): 6.     CrossRef
• Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank
  Tae Seop Lim, Sujin Kwon, Sung A. Bae, Hye Yeon Chon, Seol A. Jang, Ja Kyung Kim, Chul Sik Kim, Seok Won Park, Kyoung Min Kim
  Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub]     CrossRef
• Comparison of MRI and CT based deep learning radiomics analyses and their combination for diagnosing intrahepatic cholangiocarcinoma
  Ming Cheng, Hanyue Zhang, Yimin Guo, Peijie Lyu, Jing Yan, Yin Liu, Pan Liang, Zhigang Ren, Jianbo Gao
  Scientific Reports.2025;[Epub]     CrossRef
• Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non‐Invasive Approach
  Emre Dirican, Tayibe Bal, Yusuf Onlen, Figen Sarigul, Ulku User, Nagehan Didem Sari, Behice Kurtaran, Ebubekir Senates, Alper Gunduz, Esra Zerdali, Hasan Karsen, Ayse Batirel, Ridvan Karaali, Hatice Rahmet Guner, Tansu Yamazhan, Sukran Kose, Nurettin Erbe
  Journal of Clinical Laboratory Analysis.2025;[Epub]     CrossRef
• Association of CALLY index with NAFLD in U.S. adults from NHANES 2017–2020 assessed by vibration-controlled transient elastography
  Xunge Lin, Xiaozhen Huang, Ziqun Yi, Minran Li, Xujing Liang
  Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
• The Application of Aptamer and Research Progress in Liver Disease
  Cheng Xu, Yong Tan, Li-Ye Zhang, Xiao-Jie Luo, Jiang-Feng Wu, Lan Ma, Fei Deng
  Molecular Biotechnology.2024; 66(5): 1000.     CrossRef
• Case report: Chronic hepatitis C with anti-HCV positive and serum HCV RNA negative
  Huihui Lu, Wen Deng, Yao Lu, Lu Zhang, Yao Xie, Minghui Li
  Gastroenterology & Endoscopy.2023; 1(2): 120.     CrossRef
• Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study
  Yoonseok Lee, Seryun Bae, Ji Hoon Kim, Minjung Kwak, So Yeon Jeon, Taehyung Kim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
  Journal of Clinical Medicine.2023; 12(2): 712.     CrossRef
• Circulating miR-122-5p, miR-92a-3p, and miR-18a-5p as Potential Biomarkers in Human Liver Transplantation Follow-Up
  Cristina Morsiani, Salvatore Collura, Federica Sevini, Erika Ciurca, Valentina Rosa Bertuzzo, Claudio Franceschi, Gian Luca Grazi, Matteo Cescon, Miriam Capri
  International Journal of Molecular Sciences.2023; 24(4): 3457.     CrossRef
• Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
  Tae Seop Lim, Ho Soo Chun, Soon Sun Kim, Ja Kyung Kim, Minjong Lee, Hyo Jung Cho, Seung Up Kim, Jae Youn Cheong
  Gut and Liver.2023; 17(4): 610.     CrossRef
• Decreased Bleeding-Related Adverse Events Using Track Embolization with Gelatin Sponge Slurry after Percutaneous Liver Biopsy: A Propensity Score–Matched Study
  Sungho Koh, Hoon Kwon, Lee Hwangbo, Chang Won Kim, Suk Kim, Seung Baek Hong
  Journal of Vascular and Interventional Radiology.2023; 34(12): 2128.     CrossRef
• Correlation of Inflammatory Bowel Diseases with Liver Involvement Severity in Autoimmune Hepatobiliary Pathology: Cross-Sectional Study
  Olga V. Usoltseva, Andrey N. Surkov, Goar B. Movsisyan, Alexander S. Potapov, Elena A. Kulebina, Кirill A. Kulikov, Vladislav V. Chernikov
  Current Pediatrics.2022; 21(2): 105.     CrossRef
• Towards Autonomous Robotic Biopsy—Design, Modeling and Control of a Robot for Needle Insertion of a Commercial Full Core Biopsy Instrument
  Seyed MohammadReza Sajadi, Seyed Mojtaba Karbasi, Henrik Brun, Jim Tørresen, Ole Jacob Elle, Kim Mathiassen
  Frontiers in Robotics and AI.2022;[Epub]     CrossRef
• Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B
  Sung Hwan Yoo, Tae Seop Lim, Hyun Woong Lee, Ja Kyung Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jung Il Lee, Kwan Sik Lee, Seung Up Kim
  Journal of Viral Hepatitis.2021; 28(10): 1362.     CrossRef
• Realization of improved outcomes following liver resection in hepatocellular carcinoma patients aged 75 years and older
  Jong Man Kim, Jinsoo Rhu, Sang Yun Ha, Gyu-Seong Choi, Choon Hyuck David Kwon, Gaabsoo Kim, Jae-Won Joh
  Annals of Surgical Treatment and Research.2021; 101(5): 257.     CrossRef
• Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
  Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Gi Soo Youn, Tae Suk Kim, Baek Gyu Jun, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik, Dae Hee Choi, Ki Tae Suk
  Cancers.2020; 12(11): 3347.     CrossRef

Citations

Citations to this article as recorded by  

• Surgeon-led Point-of-care Ultrasound-guided Thoracic Biopsy: A new paradigm in efficient diagnosis and resource-sparing care
  Vaibhav Gupta, Stephen D. Gowing, Rudra Pandya, Lawrence Tan, Richard Y. Liu, Sadeesh K. Srinathan, Biniam Kidane
  The Journal of Thoracic and Cardiovascular Surgery.2025; 170(2): 369.     CrossRef
• Current Trends and Impact of Liver Biopsy on Survival in Hepatocellular Carcinoma: A Korean Multicenter Analysis
  Seong Joon Chun, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Diagnostics.2025; 15(7): 818.     CrossRef
• Association of preablation tumor biopsy and long-term outcomes of colorectal liver oligometastases
  Wenqi Chen, Jianming Li, Lu Li, Rui Cui, Guangjian Liu, Ping Liang, Jie Yu
  European Journal of Radiology.2025; 187: 112089.     CrossRef
• A review of image guidance and localization methods for liver puncture robots
  Yongde Zhang, Jiabin Yang, Xuequan Huang, Chuang He
  Journal of Robotic Surgery.2025;[Epub]     CrossRef
• Deep Learning to Localize Photoacoustic Sources in Three Dimensions: Theory and Implementation
  Mardava R. Gubbi, Muyinatu A. Lediju Bell
  IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.2025; 72(6): 786.     CrossRef
• Improving diagnostic accuracy in cirrhotic patients: a comprehensive multicenter analysis of contrast-enhanced ultrasound-guided biopsy in a large cohort of 2056 patients
  Binbin Jiang, Xiang Jing, Yuxiang Wang, Xiaolin Zhu, Jing Wang, Ruiqing Du, Bin Lv, Kefeng Wang, Zhixiang Gao, Kun Yan
  La radiologia medica.2025; 130(8): 1297.     CrossRef
• Serum α-SMA is a potential noninvasive biomarker of liver fibrosis
  Irina Cardoso-Lezama, Erika Ramos-Tovar, Jaime Arellanes-Robledo, Eduardo E. Vargas-Pozada, Verónica Rocío Vásquez-Garzón, Saúl Villa-Treviño, Pablo Muriel
  Toxicology Mechanisms and Methods.2024; 34(1): 13.     CrossRef
• Highest 3-month international normalized ratio (INR): a predictor of bleeding following ultrasound-guided liver biopsy
  Nhi H. Vo, Mehmet A. Sari, Elena Grimaldi, Emmanuel Berchmans, Michael P. Curry, Muneeb Ahmed, Bettina Siewert, Alexander Brook, Olga R. Brook
  European Radiology.2024; 34(10): 6416.     CrossRef
• The Diagnostic Value of Liver Biopsy for Unexplained Liver Dysfunction: A Retrospective Study
  Ruifang Shi, Fan Yang, Hongli Wu, Yonggang Liu
  Journal of Multidisciplinary Healthcare.2024; Volume 17: 2399.     CrossRef
• Clinical significance of exosomal noncoding RNAs in hepatocellular carcinoma: a narrative review
  Jae Sung Yoo, Min Kyu Kang
  Journal of Yeungnam Medical Science.2024; 42: 4.     CrossRef
• Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
  Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
  Clinical and Molecular Hepatology.2023; 29(2): 482.     CrossRef
• Controlled attenuation parameter measured using transient elastography for the noninvasive assessment of macrovesicular steatosis in potential living liver donors
  Sunyoung Lee, Kyoung Won Kim, So Yeon Kim, Nieun Seo, Gi-Won Song, Sung-Gyu Lee
  Ultrasonography.2022; 41(1): 164.     CrossRef
• Noninvasive surrogates are poor predictors of liver fibrosis in patients with Fontan circulation
  Yu Rim Shin, Seung Up Kim, Sak Lee, Jae Young Choi, Han Ki Park, Jeong Eun Yoo, Young Nyun Park
  The Journal of Thoracic and Cardiovascular Surgery.2022; 164(4): 1176.     CrossRef
• MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
  Young-Sun Lee, Ji Eun Lee, Hyon-Seung Yi, Young Kul Jung, Dae Won Jun, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Baek-hui Kim, Jeong Woo Kim, Chang Hee Lee, Jong Eun Yeon, Juneyoung Lee, Soon Ho Um, Kwan Soo Byun
  Hepatology International.2022; 16(2): 316.     CrossRef
• Non-invasive assessment of cirrhosis using multiphasic dual-energy CT iodine maps: correlation with model for end-stage liver disease score
  Domenico Mastrodicasa, Martin J. Willemink, Celina Duran, Andrea Delli Pizzi, Virginia Hinostroza, Lior Molvin, Mohamed Khalaf, R. Brooke Jeffrey, Bhavik N. Patel
  Abdominal Radiology.2021; 46(5): 1931.     CrossRef
• Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
  Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding
  Clinical and Molecular Hepatology.2021; 27(2): 329.     CrossRef
• Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
  Tae Hyung Kim, Yoonseok Lee, Young-Sun Lee, Jeong-An Gim, Eunjung Ko, Sun Young Yim, Young Kul Jung, SeongHee Kang, Moon Young Kim, Hayeon Kim, Baek-hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
  Scientific Reports.2021;[Epub]     CrossRef
• Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression
  Jeong-An Gim, Soo Min Bang, Young-Sun Lee, Yoonseok Lee, Sun Young Yim, Young Kul Jung, Hayeon Kim, Baek-Hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun, Matias A. Avila
  PLOS ONE.2021; 16(8): e0255822.     CrossRef
• Parenchymal Extinction Mimicking Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B-Related Liver Cirrhosis
  Min Kyu Kang, Joon Hyuk Choi
  Diagnostics.2021; 11(7): 1171.     CrossRef
• Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
  Joo Hyun Oh, Hye Won Lee, Dong Hyun Sinn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
  Hepatology International.2021; 15(4): 892.     CrossRef
• The Diagnostic Accuracy of LOGIQ S8 and E9 Shear Wave Elastography for Staging Hepatic Fibrosis, in Comparison with Transient Elastography
  Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Diagnostics.2021; 11(10): 1817.     CrossRef
• Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B
  Sung Hwan Yoo, Tae Seop Lim, Hyun Woong Lee, Ja Kyung Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jung Il Lee, Kwan Sik Lee, Seung Up Kim
  Journal of Viral Hepatitis.2021; 28(10): 1362.     CrossRef
• Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
  Jung Gil Park, Jinho Jung, Kritin K. Verma, Min Kyu Kang, Egbert Madamba, Scarlett Lopez, Aed Qas Yonan, Amy Liu, Ricki Bettencourt, Claude Sirlin, Rohit Loomba
  Alimentary Pharmacology & Therapeutics.2021; 53(9): 1030.     CrossRef
• Is liver biopsy still useful in the era of non-invasive tests?
  Tae Seop Lim, Ja Kyung Kim
  Clinical and Molecular Hepatology.2020; 26(3): 302.     CrossRef
• A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen
  Haein Bak, Hayeon Kim, Sieun Lee, Yoonseok Lee, Soo-Min Bang, Young-Sun Lee
  Yonsei Medical Journal.2020; 61(12): 1060.     CrossRef
• miRNAs as Potential Biomarkers for Viral Hepatitis B and C
  Dimitri Loureiro, Issam Tout, Stéphanie Narguet, Sabrina Menasria Benazzouz, Abdellah Mansouri, Tarik Asselah
  Viruses.2020; 12(12): 1440.     CrossRef

Citations

Citations to this article as recorded by  

• PET/MRI evaluation of hepatobiliary tumors
  Joseph FRANKL, Naveen RAJAMOHAN, Jaewon YANG, Robert C. SIBLEY
  The Quarterly Journal of Nuclear Medicine and Molecular Imaging.2025;[Epub]     CrossRef
• Diagnosis and Management of Benign Liver Tumors
  Yeonjung Ha
  The Korean Journal of Gastroenterology.2025; 85(3): 314.     CrossRef
• Hepatocellular adenomas
  Hans-Christian Pommergaard, Henning Grønbæk, Eva Fallentin, Nikolaj Skou, Nicolai Aagaard Schultz, Mette Bak Nielsen, Gro Linno Willemoe
  Ugeskrift for Læger.2025; : 1.     CrossRef
• Focal Hyperechoic Hepatic Lesions in Northern Region of Saudi Arabia: Prevalence, Radiologic Features, and Clinical Relevance
  Fatimah M. Alonzi, Mohammed J. Alsaadi, Khaled Said Karam, Essa M. Alanzi, Noura K. Alhathal, Maram F. Alreshidi, Abdulrahman M. Alfuraih
  Journal of Clinical Medicine.2025; 14(19): 6987.     CrossRef
• Focal nodular hyperplasia combined with hepatocellular carcinoma with bone metastasis: a case report and literature review
  Yuliang Zhang, Xiyue Deng, Kaiyue Cao, Yang Li
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Variation in the management of benign liver tumors: A European survey and case vignette study
  Martijn P.D. Haring, Robbert J. de Haas, Frederike G.I. van Vilsteren, Joost M. Klaase, Evelien W. Duiker, Hans Blokzijl, Koert P. de Jong, Vincent E. de Meijer, Frans J.C. Cuperus, Y.S. de Boer, R.A. de Man, C.M. den Hoed, J.P.H. Drenth, M.G. Garcovich,
  Clinics and Research in Hepatology and Gastroenterology.2023; 47(3): 102094.     CrossRef
• Hepatocellular Neoplasm of Uncertain Potential of Malignancy or Well-Differentiated Hepatocellular Carcinoma Arising within Hepatocellular Adenoma
  Elisabete Campos, Roberto Silva, Sara Rodrigues, Marinho de Almeida, Joanne Lopes, Marisa Aral, Humberto Cristino, Luís Graça, Elisabete Barbosa, Neil Donald Merrett
  Case Reports in Surgery.2023; 2023: 1.     CrossRef
• Desmoplastic small round cell tumor of the liver: diagnosing a rare case on liver biopsy
  Xiao Feng, Jing Tao, Qiang Zhou, Yi-Dan Qiao, Le-Jian He, Nan Zhang
  Diagnostic Pathology.2023;[Epub]     CrossRef
• Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out?
  Christos Tsalikidis, Athanasia Mitsala, George Pappas-Gogos, Konstantinos Romanidis, Alexandra K. Tsaroucha, Michail Pitiakoudis
  Journal of Clinical Medicine.2023; 12(18): 6034.     CrossRef
• Significance of hepatocyte atypia in liver fine needle aspiration
  Susan Shyu, Syed Z. Ali
  Diagnostic Cytopathology.2022; 50(4): 186.     CrossRef
• Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results
  Helmut Denk, Daniela Pabst, Peter M. Abuja, Robert Reihs, Brigitte Tessaro, Kurt Zatloukal, Carolin Lackner
  Modern Pathology.2022; 35(1): 87.     CrossRef
• Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice
  Elvire Desjonqueres, Claudia Campani, Fabio Marra, Jessica Zucman‐Rossi, Jean‐Charles Nault
  Liver International.2022; 42(3): 492.     CrossRef
• Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report
  Caner Ercan, Mairene Coto-Llerena, John Gallon, Lana Fourie, Mattia Marinucci, Gabriel F. Hess, Jürg Vosbeck, Stephanie Taha-Mehlitz, Tuyana Boldanova, Marie-Anne Meier, Alexandar Tzankov, Matthias S. Matter, Martin H. K. Hoffmann, Luca Di Tommaso, Markus
  Communications Medicine.2022;[Epub]     CrossRef
• Comparison of the Value of Color Doppler Ultrasound and Multislice Spiral CT in the Differential Diagnosis of Benign and Malignant Nodules in the Liver
  Peiwan Jia, Ruirong Liu, Yun Liu, Yanyan Wu, Ting Dou, Yuvaraja Teekaraman
  Contrast Media & Molecular Imaging.2022;[Epub]     CrossRef
• Magnetic Resonance Imaging Findings of an Intrahepatic Bile Duct Adenoma: A Case Report
  Jie Yuan, Kun Liu, Mengxiao Liu, Songhua Zhan
  Cureus.2022;[Epub]     CrossRef
• Liver Abnormalities in Turner Syndrome: The Importance of Estrogen Replacement
  Istvan Fedor, Eva Zold, Zsolt Barta
  Journal of the Endocrine Society.2022;[Epub]     CrossRef
• Microvascular imaging: new Doppler technology for assessing focal liver lesions. Is it useful?
  A. Wilson, A.K.P. Lim
  Clinical Radiology.2022; 77(12): e807.     CrossRef
• A focalis nodularis hyperplasia multimodális kezelése
  Damján Pekli, Bálint Kokas, Dávid Bárdos, András Fülöp, Péter Pajor, Oszkár Hahn, Ildikó Illyés, Attila Kovács, Attila Szijártó
  Orvosi Hetilap.2022; 163(15): 606.     CrossRef
• CT-Based Radiomics Nomogram: A Potential Tool for Differentiating Hepatocellular Adenoma From Hepatocellular Carcinoma in the Noncirrhotic Liver
  Pei Nie, Ning Wang, Jing Pang, Guangjie Yang, Shaofeng Duan, Jingjing Chen, Wenjian Xu
  Academic Radiology.2021; 28(6): 799.     CrossRef
• Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors
  Olga Y. Burenina, Natalia L. Lazarevich, Inna F. Kustova, Daria A. Shavochkina, Ekaterina A. Moroz, Nikolay E. Kudashkin, Yuriy I. Patyutko, Alexey V. Metelin, Eduard F. Kim, Dmitry A. Skvortsov, Timofei S. Zatsepin, Maria P. Rubtsova, Olga A. Dontsova
  Journal of Cancer Research and Clinical Oncology.2021; 147(1): 49.     CrossRef
• Benign hepatocellular lesions and neoplasms: a comprehensive review
  Luiz Paulo Guido, Monica T. Garcia-Buitrago
  Diagnostic Histopathology.2021; 27(2): 85.     CrossRef
• Hepatocellular adenomas: recent updates
  Haeryoung Kim, Young Nyun Park
  Journal of Pathology and Translational Medicine.2021; 55(3): 171.     CrossRef
• Appearance of Focal Nodular Hyperplasia after Chemotherapy in Two Patients during Follow-Up of Colon Carcinoma
  L. A. de Wert, S. A. Huisman, F. Imani, D. J. de Gooyer, J. M. G. H. van Riel, P. D. Gobardhan, A. M. Rijken, Mario Ganau
  Case Reports in Surgery.2021; 2021: 1.     CrossRef
• Scoping review of clinical practice guidelines on the management of benign liver tumours
  Martijn P D Haring, Frans J C Cuperus, Evelien W Duiker, Robbert J de Haas, Vincent E de Meijer
  BMJ Open Gastroenterology.2021; 8(1): e000592.     CrossRef
• Diagnosis and surgical treatment of a rare hepatic angiomyolipoma with internal hemorrhage
  Mizelle D'Silva, Hee Young Na, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim
  Annals of Hepato-Biliary-Pancreatic Surgery.2021; 25(4): 532.     CrossRef
• Alpha‐fetoprotein and focal nodular hyperplasia: An unconventional couple
  Paul Carrier, Anne Guyot, Marilyne Debette‐Gratien, Fabien Fredon, Marie‐Pierre Teissier, François Labrousse, Véronique Loustaud‐Ratti
  JGH Open.2021; 5(11): 1316.     CrossRef
• Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome
  Morgane Van Wettere, Luisa Paulatto, Lucas Raynaud, Onorina Bruno, Audrey Payancé, Aurélie Plessier, Pierre-Emmanuel Rautou, Valérie Paradis, Dominique Cazals-Hatem, Dominique Valla, Valérie Vilgrain, Maxime Ronot
  JHEP Reports.2020; 2(3): 100097.     CrossRef
• Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI
  Cathryn L Hui, Marcela Mautone
  The British Journal of Radiology.2020;[Epub]     CrossRef
• Focal Nodular Hyperplasia and Hepatic Adenoma
  Lauren Myers, Joseph Ahn
  Clinics in Liver Disease.2020; 24(3): 389.     CrossRef
• OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd‐EOB‐DTPA uptake and correlates with risk of malignancy
  Amedeo Sciarra, Sabine Schmidt, Alessandro Pellegrinelli, Marco Maggioni, Daniele Dondossola, Jerome Pasquier, Claudia Cigala, Delfina Tosi, Nermin Halkic, Gaetano Bulfamante, Giuseppe Viale, Silvano Bosari, Charles Balabaud, Paulette Bioulac‐Sage, Christ
  Liver International.2019; 39(1): 158.     CrossRef
• MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma
  Gábor Lendvai, Tímea Szekerczés, Benedek Gyöngyösi, Krisztina Schlachter, Endre Kontsek, Adrián Pesti, Attila Patonai, Klára Werling, Ilona Kovalszky, Zsuzsa Schaff, András Kiss
  Pathology & Oncology Research.2019; 25(3): 1103.     CrossRef
• Challenging liver lesions in noncirrhotic patients: Report of three cases
  Tania Franceschini, Deborah Malvi, Lorenzo Maroni, Matteo Ravaioli, Matteo Cescon, Antonia D’Errico, Francesco Vasuri
  Therapeutic Advances in Gastrointestinal Endoscopy.2019;[Epub]     CrossRef
• Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection
  Ying Yan, Lena Allweiss, Danli Yang, Jingting Kang, Jianwen Wang, Xiangjun Qian, Ting Zhang, Hui Liu, Lu Wang, Shuhong Liu, Jianhua Sui, Xiangmei Chen, Maura Dandri, Jingmin Zhao, Fengmin Lu
  Emerging Microbes & Infections.2019; 8(1): 879.     CrossRef
• Multi-parameter ultrasound based on the logistic regression model in the differential diagnosis of hepatocellular adenoma and focal nodular hyperplasia
  Meng Wu, Ru-Hai Zhou, Feng Xu, Xian-Peng Li, Ping Zhao, Rui Yuan, Yu-Peng Lan, Wei-Xia Zhou
  World Journal of Gastrointestinal Oncology.2019; 11(12): 1193.     CrossRef
• Focal Nodular Hyperplasia in a Young Male as an Incidental Finding Associated With Acute Lithiasic Chronic Cholecystitis. Case Report and Literature Review
  José J. Gómez-Ramos, María G. Ascencio-Rodríguez, Alejandro Marín-Medina, Moises Alejandro Alatorre Jimenez, Vickramjeet Johal, Eduardo Esteban-Zubero
  Iberoamerican Journal of Medicine.2019; 1(1): 16.     CrossRef
• Primary Liver Cancers—Part 1
  Kun Jiang, Sameer Al-Diffalha, Barbara A. Centeno
  Cancer Control.2018;[Epub]     CrossRef
• Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing
  Jian Zheng, Eran Sadot, Joana A. Vigidal, David S. Klimstra, Vinod P. Balachandran, T. Peter Kingham, Peter J. Allen, Michael I. D’Angelica, Ronald P. DeMatteo, William R. Jarnagin, Andrea Ventura, Yu-Jia Chang
  PLOS ONE.2018; 13(7): e0200776.     CrossRef
• Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma
  Archana Rastogi
  World Journal of Gastroenterology.2018; 24(35): 4000.     CrossRef
• A practical diagnostic approach to hepatic masses
  Monika Vyas, Dhanpat Jain
  Indian Journal of Pathology and Microbiology.2018; 61(1): 2.     CrossRef
• Hepatocellular adenoma: Classification, variants and clinical relevance
  Paulette Bioulac-Sage, Christine Sempoux, Charles Balabaud
  Seminars in Diagnostic Pathology.2017; 34(2): 112.     CrossRef
• Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How
  Luca Di Tommaso, Massimo Roncalli
  Frontiers in Medicine.2017;[Epub]     CrossRef
• Comparison of Subtypes of Hepatocellular Adenoma to Hepatocellular Carcinoma and Non-Neoplastic Liver Tissue in Terms of PTEN Expression
  Grzegorz Szparecki, T. Ilczuk, N. Gabzdyl, B. Górnicka
  Folia Biologica.2017; 63(5-6): 202.     CrossRef
• Leberadenome und andere maligne und benigne Lebertumoren
  F. Hartmann, A. Tannapfel
  Der Gastroenterologe.2016; 11(5): 359.     CrossRef

Citations

Citations to this article as recorded by  

• Bile acid profiles in adult patients with biliary atresia who achieve native liver survival after portoenterostomy
  Masahiro Takeda, Hajime Takei, Mitsuyoshi Suzuki, Takafumi Tsukui, Koichi Tsuboi, Hiroko Watayo, Takanori Ochi, Hiroyuki Koga, Hiroshi Nittono, Atsuyuki Yamataka
  Scientific Reports.2024;[Epub]     CrossRef
• Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis
  Yung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, Te-Sheng Chang, Chao-Hung Hung, Yao-Hsu Yang, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Cheng-Shyong Wu, Yuan-Jie Ding, Jing-Hong Hu, Yu-Ting Huang, Meng-Hung Lin, Chung-Kuang Lu, Yi-Hsiung Lin, Ming-Shyan L
  Viruses.2023; 15(1): 252.     CrossRef
• Reproducibility and diagnostic accuracy of pocket-sized ultrasound devices in ruling out compensated cirrhosis of mixed etiology
  Andrea Costantino, Alessandra Piagnani, Nicoletta Nandi, Valentina Sciola, Marco Maggioni, Francesca Donato, Maurizio Vecchi, Pietro Lampertico, Giovanni Casazza, Mirella Fraquelli
  European Radiology.2022; 32(7): 4609.     CrossRef
• Application of ultrasound for the diagnosis of cirrhosis/portal hypertension
  Seul Ki Han, Moon Young Kim, Seong Hee Kang, Soon Koo Baik
  Journal of Medical Ultrasonics.2022; 49(3): 321.     CrossRef
• Video-assisted liver ultrasound training for non-radiologists: protocol and preliminary results
  Sureeporn Jangsirikul, Surachate Siripongsakun, Roongruedee Chaiteerakij
  HPB.2021; 23(6): 962.     CrossRef
• Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use
  Daniel Fuster, Xavier García-Calvo, Paola Zuluaga, Ferran Bolao, Robert Muga
  World Journal of Gastroenterology.2021; 27(23): 3223.     CrossRef
• Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography
  Mira Florea, Teodora Serban, George Razvan Tirpe, Alexandru Tirpe, Monica Lupsor-Platon
  Journal of Clinical Medicine.2021; 10(12): 2575.     CrossRef
• Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease
  Maryam Moini, Fernanda Onofrio, Bettina E. Hansen, Oyedele Adeyi, Korosh Khalili, Keyur Patel
  Scientific Reports.2021;[Epub]     CrossRef
• ANGPTL4 regulates CD163 expression and Kuppfer cell polarization induced cirrhosis via TLR4/NF-κB pathway
  Xin Zhang, Shanshan Yuan, Xin Zhang, Tao Zhang, Cunying Meng, Kun Zhuang, Shuangsuo Dang
  Experimental Cell Research.2021; 405(2): 112706.     CrossRef
• Combining hepatic surface nodularity and serum tests better predicts hepatic fibrosis stages in chronic liver disease
  Hyo Jung Cho, Jaewon Choi, Bohyun Kim, JeongGil Ko, Joon-Il Choi, Jimi Huh, Jei Hee Lee, Jai Keun Kim
  Abdominal Radiology.2021; 46(9): 4189.     CrossRef
• Ultrasonographic grayscale findings related to fibrosis in patients with non-alcoholic fatty liver disease: comparison with transient elastography and Fib-4 index
  Naoki Matsumoto, Mariko Kumagawa, Masahiro Ogawa, Masahiro Kaneko, Yukinobu Watanabe, Hiroshi Nakagawara, Ryota Masuzaki, Tatsuo Kanda, Mitsuhiko Moriyama, Masahiko Sugitani
  Journal of Medical Ultrasonics.2021; 48(3): 323.     CrossRef
• Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics
  Anastasia Schleiger, Madeleine Salzmann, Peter Kramer, Friederike Danne, Stephan Schubert, Christian Bassir, Tobias Müller, Hans-Peter Müller, Felix Berger, Stanislav Ovroutski
  Pediatric Cardiology.2020; 41(4): 736.     CrossRef
• Ultrasonographic morphological diagnosis of chronic liver disease: 2-dimensional shear wave elastography as an add-on test
  Young Seo Cho, Woo Kyoung Jeong, Yongsoo Kim
  Ultrasonography.2020; 39(3): 272.     CrossRef
• Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir
  Tae Seop Lim, Hyun Woong Lee, Jung Il Lee, In Hee Kim, Chang Hun Lee, Byoung Kuk Jang, Woo Jin Chung, Hyung Joon Yim, Sang Jun Suh, Yeon Seok Seo, Han Ah Lee, Jung Hwan Yu, Jin‐Woo Lee, Sang Gyune Kim, Young Seok Kim, Soo Young Park, Won Young Tak, Soon S
  Journal of Viral Hepatitis.2020; 27(10): 1052.     CrossRef
• Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI
  Seong Woo Kim, Youe Ree Kim, Keum Ha Choi, Eun Young Cho, Ji Soo Song, Ji-Eon Kim, Tae-Hoon Kim, Young Hwan Lee, Kwon-Ha Yoon
  American Journal of Roentgenology.2020; 215(3): 624.     CrossRef
• Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis
  Kyeong-Ah Kwak, Hyun-Jae Cho, Jin-Young Yang, Young-Seok Park
  Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
• Precision analysis of a quantitative CT liver surface nodularity score
  Andrew Smith, Elliot Varney, Kevin Zand, Tara Lewis, Reza Sirous, James York, Edward Florez, Asser Abou Elkassem, Candace M. Howard-Claudio, Manohar Roda, Ellen Parker, Eduardo Scortegagna, David Joyner, David Sandlin, Ashley Newsome, Parker Brewster, Set
  Abdominal Radiology.2018; 43(12): 3307.     CrossRef
• Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder
  Daniel Fuster, Xavier Garcia-Calvo, Paola Zuluaga, Inmaculada Rivas, Arantza Sanvisens, Jordi Tor, Robert Muga
  Drug and Alcohol Dependence.2018; 190: 195.     CrossRef
• Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death
  Andrew D. Smith, Kevin A. Zand, Edward Florez, Reza Sirous, Darya Shlapak, Frederico Souza, Manohar Roda, Jason Bryan, Amit Vasanji, Michael Griswold, Seth T. Lirette
  Radiology.2017; 283(3): 711.     CrossRef
• 2D Shear Wave Elastography of Liver in Patients with Primary Extrahepatic Portal Vein Obstruction
  Kumble S. Madhusudhan, Raju Sharma, Ragini Kilambi, Sudhin Shylendran, Shalimar, Peush Sahni, Arun K. Gupta
  Journal of Clinical and Experimental Hepatology.2017; 7(1): 23.     CrossRef
• Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis
  Gaeun Kim, Kwang Yong Shim, Soon Koo Baik
  Gut and Liver.2017; 11(1): 93.     CrossRef
• An endoplasmic reticulum protein, Nogo‐B, facilitates alcoholic liver disease through regulation of kupffer cell polarization
  Jin‐Kyu Park, Mingjie Shao, Moon Young Kim, Soon Koo Baik, Mee Yon Cho, Teruo Utsumi, Ayano Satoh, Xinsho Ouyang, Chuhan Chung, Yasuko Iwakiri
  Hepatology.2017; 65(5): 1720.     CrossRef
• Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats
  Jiong Yu, Guangshu Hao, Dan Wang, Jingqi Liu, Xiaotian Dong, Yanni Sun, Qiaoling Pan, Yang Li, Xiaowei Shi, Lanjuan Li, Hongcui Cao
  Stem Cells International.2017; 2017: 1.     CrossRef
• FIB-4 Score as a Useful Screening Test for Diagnosing Liver Fibrosis
  Kwangjin Ahn, Juwon Kim, Yoonjung Kim, Young Uh, Kap Jun Yoon
  Journal of Laboratory Medicine and Quality Assurance.2017; 39(1): 16.     CrossRef
• The need for histological subclassification of cirrhosis: a systematic review and meta‐analysis
  Gaeun Kim, Samuel S. Lee, Soon Koo Baik, Youn Zoo Cho, Moon Young Kim, Sang Ok Kwon, Seung Hwan Cha, Mee Yon Cho
  Liver International.2016; 36(6): 847.     CrossRef
• Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis
  Andrew D. Smith, Cody R. Branch, Kevin Zand, Charu Subramony, Haowei Zhang, Katherine Thaggard, Richard Hosch, Jason Bryan, Amit Vasanji, Michael Griswold, Xu Zhang
  Radiology.2016; 280(3): 771.     CrossRef
• Differential Diagnosis of Diffuse Liver Disease
  Soon Koo Baik
  Clinical Ultrasound.2016; 1(1): 1.     CrossRef
• Usefulness of Ultrasonographic Scoring System in Diagnosis of Alcoholic Cirrhosis
  Kyoung Min Moon, Soon Koo Baik
  Clinical Ultrasound.2016; 1(2): 92.     CrossRef
• Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease
  Fernando Ezquer
  World Journal of Gastroenterology.2016; 22(1): 24.     CrossRef
• Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease
  Chavdar S Pavlov, Giovanni Casazza, Marianna Semenistaia, Dimitrinka Nikolova, Emmanuel Tsochatzis, Ekaterina Liusina, Vladimir T Ivashkin, Christian Gluud
  Cochrane Database of Systematic Reviews.2016;[Epub]     CrossRef
• Mesenchymal stem cell therapy for liver fibrosis
  Young Woo Eom, Kwang Yong Shim, Soon Koo Baik
  The Korean Journal of Internal Medicine.2015; 30(5): 580.     CrossRef
• The Accuracy of Ultrasonography for the Evaluation of Portal Hypertension in Patients with Cirrhosis: A Systematic Review
  Gaeun Kim, Youn Zoo Cho, Soon Koo Baik, Moon Young Kim, Won Ki Hong, Sang Ok Kwon
  Korean Journal of Radiology.2015; 16(2): 314.     CrossRef
• Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives
  Young Woo Eom
  World Journal of Gastroenterology.2015; 21(36): 10253.     CrossRef
• Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
  Yoon Ok Jang, Moon Young Kim, Mee Yon Cho, Soon Koo Baik, Youn Zoo Cho, Sang Ok Kwon
  BMC Gastroenterology.2014;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Deep learning reconstruction of free-breathing, diffusion-weighted imaging of the liver: A comparison with conventional free-breathing acquisition
  Jiyoung Yoon, Yoonhee Lee, Sungjin Yoon, JaeKon Sung, Thomas Benkert, Jungbok Lee, So Hyun Park, Arka Bhowmik
  PLOS One.2025; 20(5): e0320362.     CrossRef
• Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid–enhanced MRI in at-risk patients
  So Hyun Park, Young Sup Shim, Bohyun Kim, So Yeon Kim, Yun Soo Kim, Jimi Huh, Ji Hyun Park, Kyung Won Kim, Seung Soo Lee
  European Radiology.2021; 31(7): 4751.     CrossRef
• Using qualitative descriptors of chronic liver disease on MRI: A practice prone to error
  Sadhna B. Nandwana, Josephine Finazzo, Lauren F. Alexander, Kelly Cox
  Clinical Imaging.2021; 74: 89.     CrossRef
• China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis B
  Shan Shan, Wei Wei, Yuanyuan Kong, Junqi Niu, Jia Shang, Wen Xie, Yuexin Zhang, Hong Ren, Hong Tang, Huiguo Ding, Yuemin Nan, Xiaoguang Dou, Tao Han, Xiaoyuan Xu, Zhongping Duan, Lai Wei, Jinlin Hou, Hui Zhuang, Hong You, Jidong Jia
  Scandinavian Journal of Public Health.2020; 48(2): 233.     CrossRef
• Usefulness of Liver Fibrosis According to Classification of Image Score System In Abdominal Ultrasonography
  An Hyun, Ji Tae-jeong, Lee Hyo-young, Im In-chul
  Journal of Radiological Science and Technology.2019; 42(3): 187.     CrossRef
• Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C
  Baek Gyu Jun, Eui Ju Park, Woong Cheul Lee, Jae Young Jang, Soung Won Jeong, Young Don Kim, Gab Jin Cheon, Young Sin Cho, Sae Hwan Lee, Hong Soo Kim, Yun Nah Lee, Sang Gyune Kim, Young Seok Kim, Boo Sung Kim
  The Korean Journal of Internal Medicine.2019; 34(5): 989.     CrossRef
• Changes in the neutrophil-to-lymphocyte ratio predict the prognosis of patients with advanced hepatocellular carcinoma treated with sorafenib
  Young Mi Hong, Ki Tae Yoon, Tae Ho Hwang, Jeong Heo, Hyun Young Woo, Mong Cho
  European Journal of Gastroenterology & Hepatology.2019; 31(10): 1250.     CrossRef
• Clinical Significance of Urinary Neutrophil Gelatinase-associated Lipocalin Levels in Defining the Various Etiologies of Acute Kidney Injury in Liver Cirrhosis Patients
  Jong Ho Lee, Eileen L. Yoon, Seong Eun Park, Ji Young Park, Jeong Min Choi, Tae Joo Jeon, Won Chang Shin, Won-Choong Choi
  The Korean Journal of Gastroenterology.2019; 74(4): 212.     CrossRef
• Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma
  Seung Kak Shin, Duck Joo Choi, Ju Hyun Kim, Yun Soo Kim, Oh Sang Kwon
  Medicine.2018; 97(41): e12781.     CrossRef
• Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver
  Hyo Jung Cho, Bohyun Kim, Jung-Dong Lee, Dae Ryong Kang, Jai Keun Kim, Jei Hee Lee, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Soon Sun Kim, Jae Youn Cheong, Sung Won Cho
  American Journal of Gastroenterology.2017; 112(3): 460.     CrossRef
• Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death
  Andrew D. Smith, Kevin A. Zand, Edward Florez, Reza Sirous, Darya Shlapak, Frederico Souza, Manohar Roda, Jason Bryan, Amit Vasanji, Michael Griswold, Seth T. Lirette
  Radiology.2017; 283(3): 711.     CrossRef
• Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
  Jae Yoon Jeong, Joo Hyun Sohn, Won Sohn, Chan Hyuk Park, Tae Yeob Kim, Dae Won Jun, Yongsoo Kim, Woo Kyoung Jeong
  Gut and Liver.2017; 11(6): 852.     CrossRef
• Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma
  Tianhui Liu, Mingjie Yao, Shuhong Liu, Lu Wang, Leijie Wang, Jinlin Hou, Xiong Ma, Jidong Jia, Jingmin Zhao, Hui Zhuang, Fengmin Lu
  Oncotarget.2017; 8(10): 16498.     CrossRef
• Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis
  Andrew D. Smith, Cody R. Branch, Kevin Zand, Charu Subramony, Haowei Zhang, Katherine Thaggard, Richard Hosch, Jason Bryan, Amit Vasanji, Michael Griswold, Xu Zhang
  Radiology.2016; 280(3): 771.     CrossRef
• Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
  Jae-Jun Shim, In Hwan Oh, Sang Bae Kim, Jung Wook Kim, Chang Kyun Lee, Jae Young Jang, Ju-Seog Lee, Byung-Ho Kim
  Gut and Liver.2016; 10(6): 962.     CrossRef
• Prevalence, Risk Factors and Clinical Characteristics in Patients with Genotype 6 Chronic Hepatitis C: A Single Institute Experience
  Seung Kak Shin, Soo Yong Park, Young Kul Jung, Eui Joo Kim, Heon Nam Lee, Jong Joon Lee, Oh Sang Kwon, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
  The Korean Journal of Gastroenterology.2015; 65(2): 105.     CrossRef
• Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation
  Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs
  Health Technology Assessment.2015; 19(9): 1.     CrossRef
• Cryotherapy for cirrhosis-based hepatocellular carcinoma: a single center experience from 1595 treated cases
  Guanghua Rong, Wenlin Bai, Zheng Dong, Chunping Wang, Yinying Lu, Zhen Zeng, Jianhui Qu, Min Lou, Hong Wang, Xudong Gao, Xiujuan Chang, Linjing An, Yan Chen, Yongping Yang
  Frontiers of Medicine.2015; 9(1): 63.     CrossRef
• Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
  Young Jip Kim, Kichan Kim, Sun Hyuk Hwang, Soon Sun Kim, Dami Lee, Jae Youn Cheong, Sung Won Cho
  Clinical and Molecular Hepatology.2013; 19(3): 300.     CrossRef
• Pattern of abnormal ultrasonographic findings in patients with clinical suspicion of chronic liver disease in Sokoto and its environs
  Sadisu Mohammrd Maàji, Abdulmuminu Yakubu, Daniel Dirioha Odunko
  Asian Pacific Journal of Tropical Disease.2013; 3(3): 202.     CrossRef
• High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma
  Yong-Ping Yang, Jian-Hui Qu, Xiu-Juan Chang, Yin-Ying Lu, Wen-Lin Bai, Zheng Dong, Hong Wang, Lin-Jing An, Zhong-Xian Xu, Chun-Ping Wang, Zhen Zeng, Ke-Qin Hu
  Journal of Translational Medicine.2013;[Epub]     CrossRef
• Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B
  Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Chang Bum Bae, Han Gyeol Kim, Young Jip Kim, Seung Kyung Lee, Ga Won Song, Dong Joon Kim, Seong Gyu Hwang, Jin Mo Yang, Young Bae Kim, Young Nyun Park, Sung Won Cho, Jae Youn Cheong
  Clinical Biochemistry.2012; 45(18): 1564.     CrossRef
• Revision and update on clinical practice guideline for liver cirrhosis
  Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Ch
  The Korean Journal of Hepatology.2012; 18(1): 1.     CrossRef
• The prevalence and long term outcome of occult hepatitis B virus infections in community based populations
  G.Y. Minuk, K. Kowalec, S. Caouette, B. Larke, C. Osiowy
  Journal of Medical Virology.2012; 84(9): 1369.     CrossRef
• Accuracy of Routine Clinical Ultrasound for Staging of Liver Fibrosis
  Chih-Ching Choong, Sudhakar K. Venkatesh, Edwin P. Y. Siew
  Journal of Clinical Imaging Science.2012; 2: 58.     CrossRef

Citations

Citations to this article as recorded by  

• Corydalis speciosa Maxim. is a day-neutral plant with an obligate cold requirement
  Ji Woo Park, Nam Hyun Im, Hyo Beom Lee
  Scientia Horticulturae.2024; 325: 112686.     CrossRef
• Corydalis and Drug-Induced Liver Injury: A Series of 2 Cases
  Samuel Engman, Frances Puello, Kevin Khoury, Dustin Michael Miller, Kadir Isidan, Dhiren Shah
  ACG Case Reports Journal.2023; 10(12): e01230.     CrossRef
• Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases
  Rolf Teschke, Yun Zhu, Jing Jing
  Journal of Clinical and Translational Hepatology.2020; 8(2): 200.     CrossRef
• Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis
  Rolf Teschke, Gaby Danan
  Medicines.2020; 7(10): 62.     CrossRef
• Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation
  Christian Frenzel, Rolf Teschke
  International Journal of Molecular Sciences.2016; 17(5): 588.     CrossRef
• Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs
  Rolf Teschke, Dominique Larrey, Dieter Melchart, Gaby Danan
  Medicines.2016; 3(3): 18.     CrossRef
• Systematic review on herb-induced liver injury in Korea
  Woo-Jin Lee, Hae-Won Kim, Hyun-Yong Lee, Chang-Gue Son
  Food and Chemical Toxicology.2015; 84: 47.     CrossRef
• RUCAM in Drug and Herb Induced Liver Injury: The Update
  Gaby Danan, Rolf Teschke
  International Journal of Molecular Sciences.2015; 17(1): 14.     CrossRef
• Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases
  Rolf Teschke, Li Zhang, Hongzhu Long, Alexander Schwarzenboeck, Wolfgang Schmidt-Taenzer, Alexander Genthner, Albrecht Wolff, Christian Frenzel, Johannes Schulze, Axel Eickhoff
  Annals of Hepatology.2015; 14(1): 7.     CrossRef
• A Pediatric Case of Toxic Hepatitis Induced by Hovenia Dulcis
  Yun Ji Kim, Seung Lok Ryu, Jae Won Shim, Duk Soo Kim, Jung Yeon Shim, Moon Soo Park, Hye Lim Jung
  Pediatric Gastroenterology, Hepatology & Nutrition.2012; 15(2): 111.     CrossRef
• A Pediatric Case of Toxic Hepatitis Induced by Hovenia Dulcis
  Yun Ji Kim, Seung Lok Ryu, Jae Won Shim, Duk Soo Kim, Jung Yeon Shim, Moon Soo Park, Hye Lim Jung
  Pediatric Gastroenterology, Hepatology & Nutrition.2012; 15(2): 111.     CrossRef

Citations

Citations to this article as recorded by  

• Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway
  Wonhee Hur, Joon Ho Lee, Sung Woo Kim, Jung-Hee Kim, Si Hyun Bae, Minhyung Kim, Daehee Hwang, Young Seok Kim, Taesun Park, Soo-Jong Um, Byoung-Joon Song, Seung Kew Yoon
  The International Journal of Biochemistry & Cell Biology.2015; 64: 265.     CrossRef
• Oleuropein prevents the progression of steatohepatitis to hepatic fibrosis induced by a high-fat diet in mice
  Sung Woo Kim, Wonhee Hur, Tian Zhu Li, Young Ki Lee, Jung Eun Choi, Sung Woo Hong, Kwang-Soo Lyoo, Chan Ran You, Eun Sun Jung, Chan Kun Jung, Taesun Park, Soo-Jong Um, Seung Kew Yoon
  Experimental & Molecular Medicine.2014; 46(4): e92.     CrossRef
• Validity and reliability of the nonalcoholic fatty liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors
  Kyung-Hun Lee, Sang Hoon Park, Yu Jin Kim, Kyung Rim Huh, Kwang Seon Min, Sun-Young Jun, Kyoung Oh Kim, Cheol Hee Park, Taeho Hahn, Kyo-Sang Yoo, Jong Hyeok Kim, Myung-Seok Lee, Choong Kee Park
  The Korean Journal of Hepatology.2010; 16(1): 29.     CrossRef

Citations

Citations to this article as recorded by  

• Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study
  Anil Alpsoy, Haydar Adanir, Zeynep Bayramoglu, Gulsum Ozlem Elpek
  World Journal of Hepatology.2022; 14(1): 260.     CrossRef
• Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
  Sun Young Yim, Tae Hyung Kim, Suh Sang Jun, Eun Sun Kim, Bora Keum, Yeon Seok Seo, Hyung Joon Yim, Yoon Tae Jeen, Hoon Jai Chun, Hong Sik Lee, Soon Ho Um, Chang Duck Kim, Nam Hee Won, Ho Sang Ryu
  Gut and Liver.2017; 11(3): 417.     CrossRef
• Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients
  Jeong Guil Lee, Seong Gyu Hwang, Harry Yoon, Myung Su Son, Dae Young Kim, Jeong Hwan Yoo, Kwang Il Kim, Kyu Sung Rim
  Gut and Liver.2013; 7(4): 462.     CrossRef